Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy

We compared the short-term outcomes between 3-monthly aflibercept and brolucizumab injections for treatment-naïve polypoidal choroidal vasculopathy (PCV). A total of 52 eyes were included. Patients received 3 monthly intravitreal aflibercept (n = 38) or intravitreal brolucizumab (n = 14). Indocyanin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Yoshiko, Sakurada, Yoichi, Matsubara, Mio, Hasebe, Yuka, Sugiyama, Atsushi, Kikushima, Wataru, Kashiwagi, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469297/
https://www.ncbi.nlm.nih.gov/pubmed/34572350
http://dx.doi.org/10.3390/biomedicines9091164

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469297/
https://www.ncbi.nlm.nih.gov/pubmed/34572350
http://dx.doi.org/10.3390/biomedicines9091164

Ejemplares similares